DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Tasmar (Tolcapone) - Congestive Cardiomyopathy - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Congestive Cardiomyopathy (2)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Tasmar (Tolcapone) where reactions include congestive cardiomyopathy. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Tasmar side effects in 75 year old male

Reported by a physician from Germany on 2012-04-18

Patient: 75 year old male, weighing 79.0 kg (173.8 pounds)

Reactions: Cardiac Failure, Atrial Fibrillation, Pleural Effusion, Congestive Cardiomyopathy, Generalised Oedema

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Tasmar
    Indication: Parkinson's Disease
    Start date: 2010-10-07
    End date: 2011-12-01

L-Dopa-Retard

Other drugs received by patient: Madopar; Clarium; L-Dopa; Azilect



Possible Tasmar side effects in 75 year old male

Reported by a physician from Germany on 2012-04-18

Patient: 75 year old male, weighing 79.0 kg (173.8 pounds)

Reactions: Cardiac Failure, Congestive Cardiomyopathy, Pleural Effusion, Atrial Fibrillation, Generalised Oedema

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Tasmar
    Indication: Parkinson's Disease
    Start date: 2010-10-07
    End date: 2011-12-01

L-Dopa-Retard

Other drugs received by patient: Clarium; Azilect; Madopar; L-Dopa

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017